With a broad, strategic suite of programs, Goldman Sachs views BioNTech as “being at the nexus of significant developments ...

Published, peer-reviewed research shows a patent-pending, virus-mimicking platform technology developed at Purdue University ...

Scientists can peer into cells to get a limited view of their activity using microscopes and other tools. However, cells and ...

A new cancer therapy wakes up immune cells inside tumors and turns them against cancer.

Yesterday we explored four key myths and why they don’t stand up to scrutiny: ‘Vaccines were never properly tested’ ...

We recently published 10 Stocks Jim Cramer Talked About . Moderna Inc. (NASDAQ:MRNA) is one of the stocks on Jim Cramer ...

Scientists have transformed enigmatic cell structures, called vaults, into storage units for messenger-RNA molecules made in ...

The NIH is a great institution. For the health and welfare of the nation — and here in Utah — it should be protected ...

An LMU research team led by Professor Olivia M. Merkel, Chair of Drug Delivery at LMU, has developed a new delivery system ...

BK and CaV1.3 channels interact early during biogenesis, assembling intracellularly before membrane localization, indicating coordinated processes for functional coupling.

Bispecific T-cell engagers (TCEs) aim to combat cancer by simultaneously binding T cells and tumor cells in order to induce the first to kill the second. This approach has failed to work effectively ...

In recent years, messenger RNA (mRNA) vaccines have shown significant success in preventing viral and bacterial infections, ...